Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novo nordisk a::S crawled time : 20:00 save search
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Published: 2024-03-08 (Crawled : 20:00) - prnewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
fda obesity first treatment risk heart
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-02-01 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -1.75%
H: 0.74%
C: -0.05%
Novo Nordisk A/S - share repurchase programme
Published: 2023-11-13 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -1.07%
H: 0.09%
C: -0.5%
repurchase
Novo Nordisk A/S - share repurchase programme
Published: 2023-04-03 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -0.5%
H: 0.82%
C: 0.79%
repurchase
Global Best Selling Pharmaceutical Drugs Analysis Report 2023: Revenue Forecast of the Top 50 Pharmaceutical Drugs and Assessment of their Regulatory Landscape through 2021
Published: 2023-03-10 (Crawled : 20:00) - prnewswire.com
AMGN | News | $271.91 1.11% 1.12% 1.4M
|
Health Technology
| Email alert
Add to watchlist
CSLLY | $89.17 2.7% 3.3% 54K
|
n/a
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.305 0.52% -14.18% 630
|
Health Technology
| Email alert
Add to watchlist
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
| Email alert
Add to watchlist
ENDP | News | $0.2926 -9.6%
|
Health Technology
| Email alert
Add to watchlist
ALPMY | News | $9.53 0.32% -1.11% 690K
|
Manufacturing
| Email alert
Add to watchlist
VTRS | News A | $11.235 -0.13% -0.13% 5.1M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 5.4% 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $64.535 -4.38% 3.5K
|
Manufacturing
| Email alert
Add to watchlist
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
| Email alert
Add to watchlist
ALPMF | News | $9.75 6.33% 43.47% 52
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 77
|
Health Technology
| Email alert
Add to watchlist
BHC | $8.45 -2.76% 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
UCBJF | $128.725 -39.66% 750
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
| Email alert
Add to watchlist
CMXHF | $176.0 1.59% -19.21% 50
|
n/a
| Email alert
Add to watchlist
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
GSK | News | $40.59 2.11% 0.57% 3.5M
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
global report
Novo Nordisk A/S - share repurchase programme
Published: 2023-02-07 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: 0.85%
H: 0.09%
C: -0.85%
repurchase
Global Insulin Pen Market Analysis & Forecasts, 2021-2022 & 2023-2027: Focus on United States, India, China, Brazil, Saudi Arabia, United Kingdom, Germany, Netherlands, Sweden, Switzerland, Australia
Published: 2022-12-22 (Crawled : 20:00) - prnewswire.com
TRUMF | $16.74 -17.59% 1.3K
|
Health Technology
|
| O: 3.99%
H: 0.0%
C: -0.64%
TRUMY | $16.43 0.79% 34K
|
Manufacturing
|
| O: -1.16%
H: 2.28%
C: 1.1%
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -0.04%
H: 0.33%
C: 0.33%
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -0.13%
H: 0.84%
C: 0.84%
global australia insulin market
Novo Nordisk A/S purchases B shares worth DKK 3,582 million from Novo Holdings A/S under the 2022 share repurchase programme
Published: 2022-11-04 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Novo Nordisk A/S – Share repurchase programme
Published: 2022-11-04 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
repurchase
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2022-11-04 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
Global GLP-1 Receptor Agonist Market Research Report to 2027 - Featuring Novo Nordisk, PegBio and Sanofi Among Others
Published: 2022-04-26 (Crawled : 20:00) - prnewswire.com
AZNCF | News | $138.73 1.86% -4.19% 3.6K
|
Health Technology
|
| O: 3.45%
H: 0.0%
C: -3.43%
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -0.91%
H: 1.47%
C: 0.53%
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
AZN | News | $70.13 2.31% 2.24% 4.3M
|
Health Technology
|
| O: 1.94%
H: 0.59%
C: -0.2%
AMGN | News | $271.91 1.11% 1.12% 1.4M
|
Health Technology
|
| O: -0.33%
H: 1.2%
C: -0.1%
NMTR | $0.0722 -42.97% -67.9% 10M
|
Health Technology
|
| O: -0.22%
H: 5.12%
C: -0.7%
research report sanofi market
Drugs For Hormonal Replacement Therapy Global Market Report 2021
Published: 2021-11-11 (Crawled : 20:00) - prnewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: 0.0%
NVS | News | $95.12 0.81% 5.43% 2.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
therapy drug
Global Biopharmaceutical Markets 2021-2026 - Focus on mAB, Recombinant Growth Factors, Purified Proteins, Proteins, Hormones, Vaccines, Synthetic Immunomodulators, Enzymes, & Cell and Gene Therapies
Published: 2021-08-25 (Crawled : 20:00) - prnewswire.com
TAK | News | $13.36 0.91% 0.0% 1.5M
|
Health Technology
|
| O: -0.65%
H: 0.18%
C: -0.06%
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
|
| O: 0.19%
H: 0.54%
C: -0.25%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.16%
H: 0.44%
C: -0.37%
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: 0.05%
H: 0.6%
C: -1.02%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.04%
H: 1.27%
C: 0.63%
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: 0.37%
H: 0.19%
C: -0.25%
biopharma gene therapies vaccine growth hormone gene therapy therapy
Novo Nordisk A/S purchases B shares worth DKK 2,586 million from Novo Holdings A/S under the 2021 share repurchase programme
Published: 2021-05-07 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
Novo Nordisk A/S – Share repurchase programme
Published: 2021-05-07 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
s
Trading in Novo Nordisk shares by board members, executives and associated persons on 7 May 2021
Published: 2021-05-07 (Crawled : 20:00) - globenewswire.com
NVO | News | $125.26 2.08% 0.98% 3.5M
|
Health Technology
| Email alert
Add to watchlist
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
Your saved searches
Save your searches and get alerts when important news are released.